- active not recruitingNA
Amyloidosis TTR Flow Reserve Evaluation
This study looks at a heart condition called amyloidosis, where unusual protein builds up in the heart. We're using a special scan (SPECT) to see how blood flows to the heart muscle. We want to understand why some people with this condition get chest pain, even without blocked arteries.
France - recruitingPHASE1, PHASE2
Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy
This study looks at whether a plant-based substance called genistein can help people with a heart condition called Amyloid Cardiomyopathy. We want to see if it's safe, reduces swelling, and improves heart function and walking ability.
Canada - recruitingPHASE3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
This study looks at a new drug, acoramidis, for people who have a faulty gene that can cause a condition called ATTR. It aims to see if the drug can stop or slow down the disease from developing in people who don't yet have symptoms.
United States · Argentina · Australia